search-icon
AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Intel’s breakup begins with sale of $8.75B-valued Altera to private equity giant Silver Lake
2
Deel CEO Alex Bouaziz surfaces in Dubai as Rippling struggles to serve lawsuit
3
Fintech Tapcheck raises $225M—$25M Series A extension and $200M facility—to expand real-time pay
4
Armis president sets bold goal: $1B in sales in three years, IPO in two
5
Deel CEO not served in Rippling lawsuit as whistleblower placed under 24/7 guard
More news Buzzmore

Epitomee

4 stories about Epitomee
גלולת הרזיה של אפיטומי

Epitomee surges 200% in two days on FDA approval for weight loss pill

16.09.24|Adiel Eithan Mustaki
Investors are hopeful, but the company must now face an uphill battle in a crowded market.
גלולת הרזיה של אפיטומי

Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement

04.12.23|Adiel Eithan Mustaki
The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level
גלולה של חברת אפיטומי epitomee

Weight loss pill success sparks stock surge at Epitomee Medical

04.09.23|Adiel Eithan Mustaki
The company, which has not yet published the full results of its study, plans to seek FDA approval via the 510(k) pathway
default image

Weight-Loss Pill Developer Epitomee Raises $8 Million

10.04.19|CTech
Epitomee develops an orally administered capsule that affects the stomach through mechanosensory stimulation, encouraging prolonged gastric emptying and giving patients the sensation of being full
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1